Companies / OS Therapies Inc

OS Therapies Inc

NYSE: OSTXCIK 1795091ROCKVILLE, MD

Financials

Revenue
Net income$-28.75M
Total debt$250.0K
Cash
Diluted EPS$-0.98
Shares outstanding44.5M

Ownership

44.5M shares outstanding · as of May 14, 2026
4.6%Institutions
Ownership
Institutions4.58%2,038,535
Public float95.42%42,499,571

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Acevedo Christopher P.Chief Financial Officer
Ciccio JohnDirector
Galzahr KarimFormerDirector
Petit RobertSee Remarks
Romness Paul A.CEOPresident and CEO · Director

Institutional holders 27

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon Stock$344.0K+181K
+294.76%
242,479
0.54% of shares
low
Q1 2026
as of
Marshall Wace, LLP
13F manager
ExitCommon Stock$-153.9K-110K
-100.00%
0
low
Q2 2026
as of
State Street Corporation
13F manager
AddCommon Stock$117.0K+62K
+105.30%
120,100
0.27% of shares
low
Q1 2026
as of
Two Sigma Investments, LP
13F manager
TrimCommon Stock$-86.2K-61K
-69.86%
26,380
0.06% of shares
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$47.9K+34K
+13.82%
280,045
0.63% of shares
low
Q1 2026
as of
Sanders Morris Harris LLC
13F manager
NewCommon Stock$45.1K+32K
32,000
0.07% of shares
low
Q1 2026
as of
Millennium Management LLC
13F manager
ExitCommon Stock$-43.1K-31K
-100.00%
0
low
Q2 2026
as of
Quadrature Capital Ltd
13F manager
NewCommon Stock$29.8K+16K
15,662
0.04% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
OSTXCommon StockEquity68764Y207BBG00Y71N7G7